|
Olympus reviewed the following literature titled "emergent treatment using balloon-assisted ercp versus eus-guided drainage for acute cholangitis in patients with surgically altered anatomy.¿ background: no studies have compared balloon-assisted endoscope-guided endoscopic retrograde cholangiopancreatography (bae-ercp) and endoscopic ultrasonography-guided biliary drainage (eus-bd) for emergent treatment of acute cholangitis (ac) in patients with upper gastrointestinal surgically altered anatomy (saa).Methods: this study retrospectively evaluated consecutive patients who underwent emergent bae-ercp or eus-bd for ac with saa between january 2020 and march 2024.Technical success, clinical success, procedure time, and adverse events (aes) were compared between the two groups.Results: this study included 23 patients in the bae-ercp group and 14 patients in the eus-bd group.Technical success and clinical success rates did not significantly differ between the two groups (88% vs.100%, p = 0.51 and 95% vs.93%, p = 0.66).Similarly, the rate of aes was comparable between the two groups (4% vs.14%, p = 0.54).The median procedure time was significantly shorter in the eus-bd group than in the bae-ercp group (32.5 [interquartile range; iqr, 28.8¿52.5] minutes vs.70.0 [iqr, 60.0¿90.0] minutes, p < 0.01).In cases with grade 2 or 3 cholangitis, the rates of technical success, clinical success, and aes did not significantly differ between the two groups.However, the median procedure time was significantly shorter in the eus-bd group than in the bae-ercp group (32.5 [iqr, 28.8¿52.5] minutes vs.70 [iqr, 56.3¿90.0] minutes, p < 0.01).Conclusion: while both bae-ercp and eus-bd can be performed safely and effectively in patients with ac and saa, the procedure time is significantly shorter with eus-bd than with bae-ercp.Type of adverse events/number of patients peritonitis (2 patients).
|
|
This supplemental report is being submitted to provide the results of the legal manufacturer's final investigation.Updated fields: b5, h6.The device was not returned for evaluation; therefore, a definitive root cause could not be determined.The most probable cause was not established; the investigation findings do not lead to a clear conclusion about the cause of the reported adverse event.Olympus will continue to monitor field performance for this device.
|